A Phase II, Multicenter, Randomized, Fasting, Double-Blind, Placebo-Controlled, Safety, Tolerability and Efficacy Study Evaluating a Single Dose of Intravenous NA-1 in Male and Female Patients Undergoing Endovascular Repair of Brain Aneurysms.
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2015
At a glance
- Drugs NA 1 (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms ENACT
- Sponsors NoNO
- 22 Jul 2011 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 22 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Dec 2010 Planned End Date changed from 1 Sep 2010 to 1 Jun 2011 as reported by ClinicalTrials.gov.